{"id":"W4239343903","doi":"10.1017/cjn.2019.126","title":"P.026 Response to eculizumab in patients with myasthenia gravis recently treated with chronic intravenous immunoglobulin","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Eculizumab; Medicine; Placebo; Interim analysis; Refractory (planetary science); Myasthenia gravis; Internal medicine; Randomized controlled trial; Gastroenterology; Antibody; Immunology; Complement system","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009387746,0.0003384633,0.0007448721,0.0002748108,0.0002059397,0.0004681411,0.0002733373,0.000417473,0.003489674],"category_scores_gemma":[0.001383314,0.0001093265,0.0008761278,0.0003123641,0.0001793134,0.000239051,0.0001929218,0.0003988374,0.0004813458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002579631,"about_ca_system_score_gemma":0.0002763802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003492293,"about_ca_topic_score_gemma":0.0004720004,"domain_scores_codex":[0.9995815,0.0001769025,0.00006435344,0.00006745713,0.00005732503,0.00005241616],"domain_scores_gemma":[0.9993051,0.0002205439,0.0002302015,0.00003141168,0.00006973525,0.0001430228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.203017,0.002205868,0.6344024,0.00108291,0.004362689,0.001584826,0.0002564962,0.0006684116,0.01353569,0.0001436203,0.004174958,0.1345651],"study_design_scores_gemma":[0.0374285,0.07070114,0.874526,0.0002298544,0.002819916,0.0041215,0.0002954573,0.002023133,0.002188369,0.000265512,0.005369675,0.00003096525],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947142,0.003233871,0.00008948179,0.000349769,0.00005762994,0.00009867905,0.0003337687,0.000009645637,0.001112944],"genre_scores_gemma":[0.9986259,0.0003546831,0.0001270353,0.0001769935,0.000111663,0.00005618426,0.0002926437,0.000002984147,0.0002520116],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003489674,"threshold_uncertainty_score":0.01167411,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01017291363400628,"score_gpt":0.2274984596422602,"score_spread":0.2173255460082539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}